Omkar Speciality Chemicals is planning to invest INR250m ($4.67m) to expand the production capacity from current 1,700 to 1,950 tons at its active pharmaceutical ingredient (API) facility in Badlapur, Maharashtra, India. Omkar Speciality ...
Omkar Speciality Chemicals has advanced into pharmaceutical business with the acquisition of LASA Laboratory, which consists of an API manufacturing facility. The purchase is expected to allow the company to focus on manufacturing ...